Biogen Idec Expands its Neurology Pipeline by Acquiring Three Programmes from Neurimmune
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 1 (Table of Contents)
Published: 17 Jan-2011
DOI: 10.3833/pdr.v2011.i1.1421 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Biogen Idec has struck a second deal with Neurimmune, this time agreeing to purchase one of the company’s subsidiaries for up to US$427...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018